Stillbirth Clinical Trial
Official title:
Revealed Versus Concealed Criteria for Placental Insufficiency in Unselected Obstetric Population in Late Pregnancy: a Multicenter Randomized Controlled Trial
The purpose of this study is to evaluate the role of an integrated strategy at selecting fetuses for delivery at term based on a combination of fetal biometry and cerebroplacental ratio (CPR) to reduce stillbirth rate and adverse perinatal outcome.
This is a multicenter, open-label randomized trial with groups in parallel. Singleton pregnancies are recruited after routine second trimester scan (19+0 to 22+6 weeks of gestation) and randomly allocated at that moment to revealed or concealed strategy. A routine scan will be booked at 36-37 weeks. For a reduction of the stillbirth rate of 3‰ (from 5‰ to 2‰), assuming a type I error of 5% and aiming for a power of 80% a total of 11,582 subjects (5791 per arm) were projected. The participating centers sum up 12,000 deliveries a year. It is not possible to blind participants, obstetricians, or outcome assessors to the study group. General hypothesis: A proportion of fetuses with "normal" growth as per current standards have placental insufficiency and restriction of their growth potential. These fetuses exhibit biophysical changes expressed by abnormal cerebroplacental ratio. A combination of this marker with fetal biometry for the detection of fetuses affected by fetal growth restriction could identify a group of babies on which labor induction once term is reached may prevent the occurrence of adverse outcomes. Specific hypothesis - The cerebroplacental ratio has predictive value in late pregnancy for placental insufficiency. - The cerebroplacental ratio could improve the effectiveness of late pregnancy screening for the prediction placental insufficiency-related complications. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03605511 -
TTP and aHUS in Complicated Pregnancies
|
||
Completed |
NCT02379728 -
Ghana PrenaBelt Trial: A Positional Therapy Device to Reduce Still-Birth
|
N/A | |
Not yet recruiting |
NCT01664546 -
Study of the Best Blastocyst Post Transfer by aCGH
|
N/A | |
Completed |
NCT02218931 -
ESTEEM - Effect of Simple, Targeted Diet in Pregnant Women With Metabolic Risk Factors on Pregnancy Outcomes
|
N/A | |
Recruiting |
NCT03662178 -
Investigating the Structured Use of Ultrasound Scanning for Fetal Growth
|
||
Completed |
NCT03290924 -
Accelerating Newborn Survival in Ghana Through a Low-dose, High-frequency Health Worker Training Approach
|
N/A | |
Recruiting |
NCT05901688 -
Umbilical Cord Abnormalities in the Prediction of Adverse Pregnancy Outcomes
|
||
Completed |
NCT02339077 -
Group B Streptococcus (GBS) Associated Stillbirths in a High Burden Setting
|
||
Completed |
NCT03112018 -
Strengthening Facility-based Intrapartum/Immediate Newborn Care to Reduce Mortality of Preterm Infants in Migori County, Kenya and Busoga Region, Uganda
|
N/A | |
Completed |
NCT02862925 -
Introducing Fetal Scalp Stimulation as an Adjunct to Intermittent Auscultation in Low-Resource Settings.
|
N/A | |
Completed |
NCT02318420 -
The PartoMa Project: For Improving Monitoring, Action and Triage During Labour
|
N/A | |
Recruiting |
NCT05757167 -
Improving Neonatal Health Through Rapid Malaria Testing in Early Pregnancy With High-Sensitivity Diagnostics
|
Phase 4 | |
Completed |
NCT02148952 -
BetterBirth: A Trial of the WHO Safe Childbirth Checklist Program
|
N/A | |
Active, not recruiting |
NCT01995968 -
Antenatal Detection of Fetal Growth Restriction and Stillbirths Rate.
|
N/A | |
Completed |
NCT00270530 -
Intermittent Preventive Treatment of Malaria in HIV-Seropositive Pregnant Women in Zambia
|
Phase 4 | |
Completed |
NCT04600076 -
MOMSonLINE2 ; A Pilot Study Testing Recruitment and Retention of Women of Color to an Online Support Group for Bereaved Mothers
|
N/A | |
Completed |
NCT03363308 -
Effects of a Health Workforce Capacity Building and Quality Improvement Intervention in Kinshasa
|
N/A | |
Completed |
NCT03722615 -
Epidemiology of Congenital Cytomegalovirus in a High HIV Prevalence Setting, South Africa
|
||
Recruiting |
NCT02336243 -
A Randomized Trial of Docosahexaenoic Acid Supplementation During Pregnancy to Prevent Deep Placentation Disorders
|
Phase 3 | |
Completed |
NCT00133744 -
Impact of Prenatal Vitamin/Mineral Supplements on Perinatal Mortality
|
Phase 3 |